The use of carnitine in pediatric nutrition

Nutrition in Clinical Practice

Volumn 22, Issue 2, 2007, Pages 204-213

  Crill, Catherine M ^a   Richard A Helms, ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE;

ABDOMINAL CRAMP; AMINO ACID METABOLISM; BIOAVAILABILITY; BIOSYNTHESIS; CARNITINE DEFICIENCY; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DIARRHEA; ENTERIC FEEDING; FATTY ACID OXIDATION; GASTROINTESTINAL MOTILITY DISORDER; HUMAN; MYOPATHY; NAUSEA; NEWBORN MORBIDITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PEDIATRICS; RESPIRATORY TRACT DISEASE; REVIEW; SUDDEN INFANT DEATH SYNDROME; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; CHILD; CHILD NUTRITION; INFANT; KIDNEY; LIVER; METABOLISM; METHODOLOGY; NEWBORN; OXIDATION REDUCTION REACTION; PRESCHOOL CHILD;

BIOLOGICAL AVAILABILITY; CARNITINE; CHILD; CHILD NUTRITION PHYSIOLOGY; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; LIVER; OXIDATION-REDUCTION; PARENTERAL NUTRITION;

EID: 34249656771     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426507022002204     Document Type: Review

References (74)

1. Schmidt-Sommerfeld E, Penn D, Wolf H. Carnitine deficiency in premature infants receiving total parenteral nutrition: effect of L-carnitine supplementation. J Pediatr. 1983;102:931-935.
2. Curran JS, Williams PR, Kanarek KS, Novak M, Monkus EF. An evaluation of orally supplemented L-carnitine in premature infants receiving Intralipid 20%. Acta Chir Scan Suppl. 1983;517:157-164.
3. Novak M, Monkus EF, Buch M, Lesmes H, Silverio J. The effect of an L-carnitine supplemented soybean formula on the plasma lipids of infants. Acta Chir Scand Suppl. 1983;517:149-155.
4. Orzali A, Donzelli F, Enzi G, Rubaltelli FF. Effect of carnitine on lipid metabolism in the newborn. Biol Neonate. 1983;43:186-190.
5. Orzali A, Maetzke G, Donzelli F, Rubaltelli FF. Effect of carnitine on lipid metabolism in the neonate, II: carnitine addition to lipid infusion during prolonged total parenteral nutrition. J Pediatr. 1984;104:436-440.
6. Rubecz I, Sandor A, Hamar A, Mestyan J. Blood levels of total carnitine and lipid utilization with and without carnitine supplementation in newborn infants. Acta Paediatr Hung. 1984;25:165-171.
7. Coran AG, Drongowski RA, Baker PJ. The metabolic effects of oral L-carnitine administration in infants receiving total parenteral nutrition with fat. J Pediatr Surg. 1985;20:758-764.
8. Melegh B, Kerner J, Sandor A, Vinceller M, Kispal G. Oral L-carnitine supplementation in low-birth-weight newborns: a study on neonates requiring combined parenteral and enteral nutrition. Acta Paediatr Hung. 1986;27:253-258.
9. Helms RA, Whittington PF, Mauer EC, Catarau EM, Christensen ML, Borum PR. Enhanced lipid utilization in infants receiving oral L-carnitine during long-term parenteral nutrition. J Pediatr. 1986;109:984-988.
10. Novak M, Monkus EF, Buch M, Silverio J, Clouston OM, Cassady JM. L-carnitine supplementation of a soybean-based formula in early infancy: plasma and urine levels of carnitine and acylcarnitines. J Pediatr Gastroenterol Nutr. 1987;7:220-224.
11. Melegh B, Kerner J, Sandor A, Vinceller M, Kispal G. Effects of oral L-carnitine supplementation in low-birth weight premature infants maintained on human milk. Biol Neonate. 1987;51:185-193.
12. Melegh B, Szucs L, Kerner J, Sandor A. Changes of plasma free amino acids and renal clearances of carnitines in premature infants during L-carnitine supplemented human milk feeding. J Pediatr Gastroenterol Nutr. 1988;7:424-429.
13. Olson AL, Nelson SE, Rebouche CJ. Low carnitine intake and altered lipid metabolism in infants. Am J Clin Nutr. 1989;49:624-628.
14. Melegh B, Kerner J, Szucs L, Porpaczy Z. Feeding preterm infants with L-carnitine supplemented formula. Acta Paediatr Hung. 1990;30:27-41.
15. Sulkers EJ, Lafeber HN, Degenhart HJ, Przyrembel H, Schlotzer K, Sauer JP. Effects of high carnitine supplementation on substrate utilization in low-birth-weight infants receiving total parenteral nutrition. Am J Clin Nutr. 1990;52:889-894.
16. Larsson IF, Olegard R, Ljung ML, Niklasson A, Rubensson A, Cederblad G. Parenteral nutrition in preterm neonates with and without carnitine supplementation. Acta Anaesthesiol Scand. 1990;34:501-505.
17. Helms RA, Mauer EC, Hay WW, Christensen ML, Storm MC. Effect of intravenous L-carnitine on growth parameters and fat metabolism during parenteral nutrition in neonates. JPEN J Parenter Enteral Nutr. 1990;14:448-453.
18. Bonner CM, DeBrie KL, Hug G, Landrigan E, Taylor BJ. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates. J Pediatr. 1995;126:287-292.
19. Hirose S, Hirata M, Azuma N, Shirai Z, Mitudome A, Oda T. Carnitine depletion during total parenteral nutrition despite oral L-carnitine supplementation. Acta Paediatr Jpn. 1997;39:194-200.
20. Shortland GJ, Walter JH, Stroud C, Fleming PJ, Speidel PD, Marlow N. Randomised controlled trial of L-carnitine as a nutritional supplement in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1998;78:F185-F188.
21. O'Donnell, Finer NN, Rich W, Barshop BA, Barrington KJ. Role of L-carnitine in apnea of prematurity: a randomized, controlled trial. Pediatrics. 2002;109:622-626.
22. Whitfield J, Smith T, Sollohub H, Sweetman L, Roe CR. Clinical effects of L-carnitine supplementation on apnea and growth in very low birth weight infants. Pediatrics. 2003;111:477-482.
23. Pande S, Brion LP, Campbell DE, Gayle Y, Esteban-Cruciani NV. Lack of effect of L-carnitine supplementation on weight gain in very preterm infants. J Perinatol. 2005;25:470-477.
24. Crill CM, Storm MC, Christensen ML, Hankins CT, Bruce Jenkins M, Helms RA. Carnitine supplementation in premature neonates: effect on plasma and red blood cell total carnitine concentrations, nutrition parameters and morbidity. Clin Nutr. 2006;25:886-896.
25. Borum PR. Carnitine in neonatal nutrition. J Child Neurol. 1995;10(suppl):2S25-2S31.
26. Borum PR. Carnitine function. In: Borum PR, ed. Clinical Aspects of Human Carnitine Deficiency. Elmsford, NY: Pergamon Press; 1986:16-27.
27. Rebouche CJ. Carnitine function and requirements during the life cycle. FASEB J. 1992;6:3379-3386.
28. Bieber LL. Carnitine. Ann Rev Biochem. 1988;57:261-283.
29. Feller AG, Rudman D. Role of carnitine in human nutrition. J Nutr. 1988;118:541-547.
30. Siliprandi N, Sartorelli L, Ciman M, et al. Carnitine: metabolism and clinical chemistry. Clin Chim Acta. 1989;183:3-12.
31. Crill CM, Wang B, Storm MC, Helms RA. Carnitine: a conditionally essential nutrient in the neonatal population? J Pediatr Pharmacol Ther. 2001;6:225-236.
32. Hoppel C. The physiological role of carnitine. In: Ferrari R, Dimauro S, Sherwood G, eds. L-Carnitine and Its Role in Medicine: From Function to Therapy. San Diego, CA: Academic Press Inc; 1992:5-19.
33. DeVivo DC, Tein I. Primary and secondary disorders of carnitine metabolism. Int Pediatr. 1990;5:134-141.
34. Harpey JP, Charpentier C, Paturneau-Jouas M. Sudden infant death syndrome and inherited disorders of fatty acid β-oxidation. Biol Neonate. 1990;58:70-80.
35. Rebouche CJ. Recent advances in carnitine biosynthesis and transport. In: Borum PR, ed. Clinical Aspects of Human Carnitine Deficiency. Elmsford, NY: Pergamon Press; 1986:1-15.
36. Giovannini M, Agostoni C, Salari PC. Is carnitine essential in children? J Int Med Res. 1991;19:88-102.
37. Olson AL, Rebouche CJ. Gamma-butyrobetaine hydroxylase activity is not rate limiting for carnitine biosynthesis in the human infant. J Nutr. 1987;117:1024-1031.
38. Melegh B, Hermann R, Bock I. Generation of hydroxymethyllsine from trimethyllysine limits the carnitine biosynthesis in premature infants. Acta Paediatr. 1996;85:345-350.
39. Carter AL, Abney TO, Lapp DF. Biosynthesis and metabolism of carnitine. J Child Neurol 1995;10(suppl):2S3-2S7.
40. Schmidt-Sommerfeld E, Werner D, Penn D. Carnitine plasma concentrations in 353 metabolically healthy children. Eur J Pediatr. 1988;147:356-360.
41. Lombard KA, Olson AL, Nelson SE, Rebouche CJ. Carnitine status of lactoovovegetarians and strict vegetarian adults and children. Am J Clin Nutr. 1989;50:301-306.
42. Patera A, Neylan M, Borum PR. Plasma and red blood cell carnitine concentrations of healthy one week old infants receiving dietary carnitine. In: Borum PR, ed. Clinical Aspects of Human Carnitine Deficiency. Elmsford, NY: Pergamon Press; 1986:46-47.
43. Shenai JP, Borum PR, Mohan P, Donlevy SC. Carnitine status at birth of newborn infants of varying gestation. Pediatr Res. 1983;17:579-582.
44. Shenai JP, Borum PR. Tissue carnitine reserves of newborn infants. Pediatr Res. 1984;18:679-682.
45. Weaver LT, Rosenthal SR, Gladstone W, Winter HS. Carnitine deficiency: a possible cause of gastrointestinal dysmotility. Acta Pediatr. 1992;81:79-81.
46. Breningstall GN. Carnitine deficiency syndromes. Pediatr Neurol. 1990;6:75-81.
47. Pons R, DeVivo DC. Primary and secondary carnitine deficiency syndromes. J Child Neurol. 1995;10(suppl):2S8-2S24.
48. Iafolla AK, Browning IB, Roe CR. Familial infantile apnea and immature beta oxidation. Pediatr Pulmonol. 1995;20:167-171.
49. Winter SC, Szabo-Aczel S, Curry CJ, et al. Plasma carnitine deficiency: clinical observations in 51 pediatric patients. Am J Dis Child. 1987;141:660-665.
50. Kendler BS. Carnitine: an overview of its role in preventive medicine. Prev Med. 1986;15:373-390.
51. Tao RC, Yoshimura NN. Carnitine metabolism and its application in parenteral nutrition. JPEN J Parenter Enteral Nutr. 1980;4:469-486.
52. Penn D, Dolderer M, Schmidt-Sommerfeld E. Carnitine concentrations in the milk of different species and infant formulas. Biol Neonate. 1987;52:70-79.
53. Melegh B. Carnitine supplementation in the premature. Biol Neonate. 1990;58(suppl 1):93-106.
54. Schiff D, Chan G, Secombe D, Hahn P. Plasma carnitine levels during intravenous feeding of the neonate. J Pediatr. 1979;95:1043-1046.
55. Penn D, Schmidt-Sommerfeld E, Wolf H. Carnitine deficiency in premature infants receiving total parenteral nutrition. Early Hum Dev. 1980;4:23-24.
56. Schmidt-Sommerfeld E, Penn D, Wolf H. Carnitine blood concentrations and fat utilization in parenterally alimented premature newborn infants. J Pediatr. 1982;100:260-264.
57. Christensen ML, Helms RA, Mauer EC, Storm MC. Plasma carnitine concentration and lipid metabolism in infants receiving parenteral nutrition. J Pediatr. 1989;115:794-798.
58. Tibboel D, Delemarre FM, Przyrembel H, Bos AP, Affourtit MJ, Mlenaar JC. Carnitine deficiency in surgical neonates receiving total parenteral nutrition, J Pediatr Surg. 1990;25:418-421.
59. Dahlstrom KA, Ament AM, Moukarzel A, Vinton NE, Cedarblad G. Low blood and plasma carnitine levels in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1990;11:375-379.
60. Moukarzel AA, Dahlstrom KA, Buchman AL, Ament ME. Carnitine status of children receiving long-term total parenteral nutrition: a longitudinal prospective study. J Pediatr. 1992;120:759-762.
61. Iafolla AK, Roe CR. Carnitine deficiency in apnea of prematurity [abstract]. Pediatr Res. 1995;2:309A (1840).
62. Kumar M, Kabra NS, Paes B. Role of carnitine supplementation in apnea of prematurity: a systematic review. J Perinatol. 2004;24:158-163.
63. Cairns PA, Stalker DJ. Carnitine supplementation of parenterally fed neonates. Cochrane Database. 2001;4:CD000950.
64. Borum PR. Is L-carnitine stable in parenteral nutrition solutions prepared for preterm neonates? Neonatal Intensive Care. 1993; Sept/Oct:30-32.
65. Storm MC, Wang B, Helms RA. Stability of carnitine in pediatric TPN and TNA formulations [abstract]. JPEN J Parenter Enteral Nutr. 1998;22:S18. Abstract 71.
66. Millington DS, Dubay G. Dietary supplement L-carnitine: analysis of different brands to determine bioavailability and content. Clin Res Reg Affairs. 1993;10:71-80.
67. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet. 2003;42:941-967.
68. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 2004;1033:30-41.
69. Carnitor package insert. Gaithersburg, MD: Sigma-Tau Pharmaceuticals, Inc., March 2004.
70. Harper P, Elwin CE, Cederblad G. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol. 1988;35:555-562. (Pubitemid 18264762)
71. Segre G, Bianchi E, Corsi M, D'Iddio S, Ghirardi O, Maccari F. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man. Arzneimittelforschung. 1988;38:1830-1834.
72. Rizza V, Lorefice R, Rizza N, et al. Pharmacokinetics of L-carnitine in human subjects. In: Ferrari R, Dimauro S, Sherwood G, eds. L-Carnitine and Its Role in Medicine: From Function to Therapy. San Diego, CA: Academic Press Inc; 1992:63-77.
73. Sahajwalla CG, Helton ED, Purich ED, Hoppel CL, Cabana BE. Multiple dose-pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J Pharm Sci. 1995;84:627-633.
74. Crill CM, Christensen ML, Storm MC, Helms RA. Relative bioavailability of carnitine supplementation in premature neonates. JPEN J Parenter Enteral Nutr. 2006;30:421-425.